Viewing Study NCT00094419



Ignite Creation Date: 2024-05-05 @ 11:39 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00094419
Status: COMPLETED
Last Update Posted: 2008-08-12
First Post: 2004-10-18

Brief Title: Complementary and Alternative Medicine Use in Low-Income African American and Caucasian Adults With Asthma
Sponsor: National Center for Complementary and Integrative Health NCCIH
Organization: National Center for Complementary and Integrative Health NCCIH

Study Overview

Official Title: The Role of Complementary and Alternative Medicine CAM Folk Care and Faith-Based Approaches in the Home Management of Persistent Asthma in Low-Income African American and Caucasian Adults
Status: COMPLETED
Status Verified Date: 2008-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to identify the types of and frequency of use of complementary and alternative medicine CAM strategies among low-income Caucasian and African American adults with persistent asthma The overall goal is to collect data that will increase understanding of health beliefs and behaviors in people with low-income backgrounds so that studies can be created that may help modify and improve patients symptoms of asthma
Detailed Description: The rates of asthma-related deaths and disease are disproportionately high among African Americans compared to Caucasians Surveys indicate that middle- and upper-income Caucasians use more CAM than African Americans but the therapies utilized are different This study will determine how well people with persistent asthma adhere to their treatment and whether the type and frequency of use of CAM affects treatment adherence

Participants will begin this study by taking part in an interview about adherence to their current inhaled corticosteroids ICS regimen and their personal CAM use After completing the interview participant adherence to their ICS regimen will be monitored for 6 weeks Depending on the type of ICS participants are taking monitoring will be conducted either by participant self-reporting or electronic monitors that record the time and date of medication inhalation Participant adherence will also be assessed at study completion

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None